R1 RCM Inc. (RCM)
USD 14.31
(0.0%)
USD 14.31
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.56 Billion USD | -12.41% |
| 2022 | 1.78 Billion USD | 152.23% |
| 2021 | 709.2 Million USD | 53.71% |
| 2020 | 461.4 Million USD | 29.06% |
| 2019 | 357.5 Million USD | 20.82% |
| 2018 | 295.9 Million USD | 279.44% |
| 2017 | -164.9 Million USD | 8.98% |
| 2016 | -181.17 Million USD | -75.05% |
| 2015 | -103.49 Million USD | 28.7% |
| 2014 | -145.16 Million USD | 36.58% |
| 2013 | -228.89 Million USD | -29.35% |
| 2012 | -176.95 Million USD | 10.05% |
| 2011 | -196.72 Million USD | -26.45% |
| 2010 | -155.57 Million USD | -256.34% |
| 2009 | -43.65 Million USD | 15.48% |
| 2008 | -51.65 Million USD | -48.67% |
| 2007 | -34.74 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 2.2 Billion USD | -0.24% |
| 2024 Q1 | 2.21 Billion USD | 41.16% |
| 2024 Q3 | 2.14 Billion USD | -2.68% |
| 2023 Q3 | 1.65 Billion USD | -5.14% |
| 2023 FY | 1.56 Billion USD | -12.41% |
| 2023 Q4 | 1.56 Billion USD | -5.05% |
| 2023 Q1 | 1.77 Billion USD | -0.91% |
| 2023 Q2 | 1.73 Billion USD | -1.86% |
| 2022 Q2 | 1.75 Billion USD | 145.17% |
| 2022 FY | 1.78 Billion USD | 152.23% |
| 2022 Q1 | 715.1 Million USD | 0.83% |
| 2022 Q4 | 1.78 Billion USD | 1.26% |
| 2022 Q3 | 1.76 Billion USD | 0.76% |
| 2021 FY | 709.2 Million USD | 53.71% |
| 2021 Q4 | 709.2 Million USD | -0.63% |
| 2021 Q3 | 713.7 Million USD | 58.42% |
| 2021 Q2 | 450.5 Million USD | -13.81% |
| 2021 Q1 | 522.7 Million USD | 13.29% |
| 2020 Q2 | 531.2 Million USD | 45.41% |
| 2020 FY | 461.4 Million USD | 29.06% |
| 2020 Q1 | 365.3 Million USD | 2.18% |
| 2020 Q3 | 538.4 Million USD | 1.36% |
| 2020 Q4 | 461.4 Million USD | -14.3% |
| 2019 Q4 | 357.5 Million USD | -11.77% |
| 2019 Q1 | 327.9 Million USD | 10.81% |
| 2019 Q2 | 398.4 Million USD | 21.5% |
| 2019 FY | 357.5 Million USD | 20.82% |
| 2019 Q3 | 405.2 Million USD | 1.71% |
| 2018 Q4 | 295.9 Million USD | -3.65% |
| 2018 Q3 | 307.1 Million USD | -4.21% |
| 2018 Q1 | -167.6 Million USD | -1.64% |
| 2018 Q2 | 320.6 Million USD | 291.29% |
| 2018 FY | 295.9 Million USD | 279.44% |
| 2017 FY | -164.9 Million USD | 8.98% |
| 2017 Q4 | -164.9 Million USD | -15.48% |
| 2017 Q3 | -142.8 Million USD | -7.85% |
| 2017 Q2 | -132.4 Million USD | 7.22% |
| 2017 Q1 | -142.7 Million USD | 21.24% |
| 2016 Q2 | -221.67 Million USD | 21.11% |
| 2016 Q1 | -280.99 Million USD | -171.5% |
| 2016 Q3 | -201.94 Million USD | 8.9% |
| 2016 FY | -181.17 Million USD | -75.05% |
| 2016 Q4 | -181.17 Million USD | 10.29% |
| 2015 FY | -103.49 Million USD | 28.7% |
| 2015 Q4 | -103.49 Million USD | 24.85% |
| 2015 Q3 | -137.71 Million USD | -12.98% |
| 2015 Q2 | -121.89 Million USD | 7.66% |
| 2015 Q1 | -132 Million USD | 9.07% |
| 2014 Q3 | -193.74 Million USD | -25.71% |
| 2014 Q4 | -145.16 Million USD | 25.07% |
| 2014 FY | -145.16 Million USD | 36.58% |
| 2014 Q1 | -207.67 Million USD | 9.27% |
| 2014 Q2 | -154.12 Million USD | 25.79% |
| 2013 Q2 | -203.7 Million USD | -11.31% |
| 2013 Q1 | -183 Million USD | -3.42% |
| 2013 FY | -228.89 Million USD | -29.35% |
| 2013 Q4 | -228.89 Million USD | -3.95% |
| 2013 Q3 | -220.2 Million USD | -8.1% |
| 2012 Q2 | -200.87 Million USD | 6.34% |
| 2012 Q3 | -196.37 Million USD | 2.24% |
| 2012 Q1 | -214.47 Million USD | -9.02% |
| 2012 Q4 | -176.95 Million USD | 9.89% |
| 2012 FY | -176.95 Million USD | 10.05% |
| 2011 Q2 | -150.29 Million USD | -26.33% |
| 2011 Q3 | -182.09 Million USD | -21.16% |
| 2011 Q4 | -196.72 Million USD | -8.03% |
| 2011 Q1 | -118.97 Million USD | 23.53% |
| 2011 FY | -196.72 Million USD | -26.45% |
| 2010 Q4 | -155.57 Million USD | -24.85% |
| 2010 Q3 | -124.61 Million USD | -3.95% |
| 2010 Q2 | -119.87 Million USD | -295.48% |
| 2010 Q1 | -30.31 Million USD | 30.57% |
| 2010 FY | -155.57 Million USD | -256.34% |
| 2009 Q3 | -34.27 Million USD | 9.31% |
| 2009 Q2 | -37.78 Million USD | 0.0% |
| 2009 Q4 | -43.65 Million USD | -27.39% |
| 2009 FY | -43.65 Million USD | 15.48% |
| 2008 Q4 | -51.65 Million USD | 0.0% |
| 2008 FY | -51.65 Million USD | -48.67% |
| 2007 FY | -34.74 Million USD | 0.0% |
| 2000 Q4 | 1.78 Billion USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 773.42 Million USD | -102.579% |
| GE HealthCare Technologies Inc. | 7.36 Billion USD | 78.738% |
| Sharecare, Inc. | -125.84 Million USD | 1345.053% |
| Progyny, Inc. | -77.9 Million USD | 2111.142% |
| Aclarion, Inc. | 94.65 Thousand USD | -1655174.418% |
| CareMax, Inc. | 426.4 Million USD | -267.443% |
| Simulations Plus, Inc. | -9.83 Million USD | 16029.24% |
| CareCloud, Inc. | 11.4 Million USD | -13641.449% |
| Forian Inc. | 16.95 Million USD | -9138.866% |
| Bullfrog AI Holdings, Inc. Warrants | -2.62 Million USD | 59793.759% |
| Bullfrog AI Holdings, Inc. Common Stock | -2.62 Million USD | 59793.759% |
| Minerva Surgical, Inc. | 32.74 Million USD | -4684.414% |
| Omnicell, Inc. | 113.11 Million USD | -1285.188% |
| Definitive Healthcare Corp. | 136.95 Million USD | -1044.05% |
| Zhongchao Inc. | -6.74 Million USD | 23344.435% |
| Accolade, Inc. | 55.93 Million USD | -2701.359% |
| Streamline Health Solutions, Inc. | 7.37 Million USD | -21141.866% |
| Ontrak, Inc. | -8.01 Million USD | 19655.667% |
| SOPHiA GENETICS SA | -104.65 Million USD | 1597.181% |
| Spok Holdings, Inc. | -20.9 Million USD | 7595.575% |
| Privia Health Group, Inc. | -381.22 Million USD | 510.994% |
| EUDA Health Holdings Limited | 3.18 Million USD | -49085.062% |
| HeartBeam, Inc. | -16.18 Million USD | 9778.177% |
| GeneDx Holdings Corp. | 20.08 Million USD | -7699.293% |
| TruBridge, Inc. | 199.44 Million USD | -685.596% |
| Nutex Health, Inc. | 253.75 Million USD | -517.446% |
| Renalytix Plc | 3.85 Million USD | -40543.32% |
| Sharecare, Inc. | -125.84 Million USD | 1345.053% |
| Health Catalyst, Inc. | 142.79 Million USD | -997.26% |
| 10x Genomics, Inc. | -263.91 Million USD | 693.678% |
| GoodRx Holdings, Inc. | 38.77 Million USD | -3940.852% |
| SCWorx Corp. | -1077.00 USD | 145478280.13% |
| Schrödinger, Inc. | -33.18 Million USD | 4821.553% |
| HealthEquity, Inc. | 529.16 Million USD | -196.09% |
| HealthStream, Inc. | -17.11 Million USD | 9256.148% |
| MSP Recovery, Inc. | 667.69 Million USD | -134.658% |
| Augmedix, Inc. | -20.49 Million USD | 7744.418% |
| BrightSpring Health Services, Inc. Common Stock | 3.65 Billion USD | 57.162% |
| Ontrak, Inc. | -8.01 Million USD | 19655.667% |
| SHL Telemedicine Ltd. | 13.15 Million USD | -11807.514% |
| CareCloud, Inc. | 11.4 Million USD | -13641.449% |
| Premier, Inc. | 855 Thousand USD | -183151.462% |
| Certara, Inc. | 63.24 Million USD | -2377.507% |
| GeneDx Holdings Corp. | 20.08 Million USD | -7699.293% |
| OneMedNet Corporation | 5.05 Million USD | -30899.298% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.65 Billion USD | 57.162% |
| EUDA Health Holdings Limited | 3.18 Million USD | -49085.062% |
| HeartBeam, Inc. | -16.18 Million USD | 9778.177% |
| CareCloud, Inc. | 11.4 Million USD | -13641.449% |
| Mangoceuticals, Inc. | -610.32 Thousand USD | 256814.422% |
| CareMax, Inc. | 426.4 Million USD | -267.443% |
| Healthcare Triangle, Inc. | 3.08 Million USD | -50720.629% |
| National Research Corporation | 32.3 Million USD | -4750.323% |
| Aclarion, Inc. | 94.65 Thousand USD | -1655174.418% |
| OptimizeRx Corporation | 22.97 Million USD | -6720.672% |